Moderna Inc (NASDAQ:MRNA)
| 103.32 Delayed Data As of Sep 29 |  +3.05 / +3.04%Today’s Change | 95.02 Today|||52-Week Range 217.25 | -42.48% Year-to-Date |
Latest MRNA News | Press Releases
Today’s Trading
| Previous close | 100.27 |
| Today’s open | 101.05 |
| Day’s range | 101.05 - 104.69 |
| Volume | 238,360 |
| Average volume (3 months) | 3,685,914 |
| Market cap | $38.1B |
Data as of 4:00pm ET, 09/29/2023
Growth & Valuation
| Earnings growth (last year) | -29.90% |
| Earnings growth (this year) | -112.01% |
| Earnings growth (next 5 years) | -51.00% |
| Revenue growth (last year) | +3.78% |
| P/E ratio | 36.0 |
| Price/Sales | 3.91 |
| Price/Book | 2.01 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BIIBBiogen | -0.82 | -0.32% |
| ILMNIllumina Inc | +4.92 | +3.72% |
| ---- | ||
| BMRNBiomarin Pharmaceuti... | -0.75 | -0.84% |
Data as of 4:00pm ET, 09/29/2023
Financials
| Next reporting date | November 2, 2023 |
| EPS forecast (this quarter) | $0.54 |
| Annual revenue (last year) | $19.1B |
| Annual profit (last year) | $8.4B |
| Net profit margin | 43.76% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
